Rejuvenating aged bone regeneration by innovative nanomaterials-mediated drug delivery
通过创新纳米材料介导的药物输送使衰老的骨再生恢复活力
基本信息
- 批准号:10391345
- 负责人:
- 金额:$ 34.78万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2020
- 资助国家:美国
- 起止时间:2020-07-01 至 2025-04-30
- 项目状态:未结题
- 来源:
- 关键词:3-DimensionalAddressAdultAgingAnti-Inflammatory AgentsAutologousAutologous TransplantationBiomimeticsBone DiseasesBone MatrixBone Morphogenetic ProteinsBone RegenerationBone TissueBone TransplantationCell TransplantationCellsCephalicChitosanChronicCost of IllnessDefectDeferoxamineDrug Delivery SystemsElasticityElderlyElectrospinningEndothelial CellsEngineeringFemaleFibrinogenGoalsGoldGrowth FactorHA coatingHIF1A geneHealthcareHormonesHumanHypoxiaImmobilizationIn SituIn VitroInflammationInflammatoryIronIron Chelating AgentsIrregular BoneKnowledgeMediatingMedicalMesenchymal Stem CellsModelingModernizationMolecularMusNatural regenerationOlder PopulationOsteogenesisPatientsPharmaceutical PreparationsPlayPolymersPopulationPrevalenceProductionProteinsRegenerative MedicineRegenerative capacityResearchRoleSafetySignal PathwaySignal TransductionSignaling ProteinSomatotropinStem cell transplantStructureSystemTechniquesThe SunTherapeuticTissue EngineeringTissuesTranslationsTransplantationWorkage relatedagedaging populationangiogenesisbonebone agingbone repaircell agecell growthchemical conjugatechemical propertyclinically relevantcombinatorialcontrolled releasecostcytokineeffectiveness evaluationhuman stem cellsimprovedinnovationlocal drug deliverymalemechanical propertiesnanofibernanomaterialsnew therapeutic targetnext generationnovelnovel strategiesosteoblast differentiationosteogenicphenylamilrecruitrepairedrestorationscaffoldsmall moleculestemsuccesstissue regenerationtranslational applications
项目摘要
PROJECT SUMMARY
Scaffold-mediated exogenous cells transplantation and growth factors/hormones delivery are
two widely-studied alternatives to conventional autologous grafts, the "gold standard." For
therapeutic translation, however, both approaches encounter various barriers, including safety
concerns. Compared to use of exogenous cells/proteins, strategies that promote tissue
regeneration by leveraging endogenous cells/signals in situ are more intriguing. Nonetheless,
changes in tissue associated with aging (iron accumulation and chronic inflammation) challenge
bone regeneration and repair, particularly in older populations. Emerging evidence suggests
that the hypoxia-induced factor-1α (HIF-1α) signaling pathway is a central driver of regeneration
and angiogenesis. Findings also show sustained activation of HIF-1α by an iron chelator (e.g.,
Deferoxamine, DFO) is a promising strategy to improve the capacity of regeneration in aged
bones where HIF-1α is markedly inhibited by elevated iron levels. Preliminary work by the Sun
lab has found that another small molecule, phenamil, shows strong anti-inflammatory ability in
addition to playing a powerful role in promoting bone formation by targeting BMP signaling. A
locally and sustained drug delivery system and a bio-mimicking scaffold are critical for
successful translational application of these promising small molecular drugs. The primary goal
of this study is to develop an innovative translational tissue engineering strategy to improve
aged large bone regeneration by rejuvenating endogenous signals and reparative cells. Our
central hypothesis is that novel bio-mimicking 3D nanofibrous (NF) scaffold-mediated dual-
release of small molecules, DFO and phenamil, can improve critical-sized bone defect repair in
aged mice through locally: (1) scavenging for detrimental aged-related factors, i.e., excessive
iron and inflammatory cytokines; and (2) activating HIF1α and BMP signaling pathways, thereby
promoting production of endogenous angiogenic and osteogenic factors, and recruitment of
reparative cells (e.g., MSCs, endothelial cells) in situ, for bone regeneration with a primary focus
on non-load-bearing bone defects. In Aim 1, we will develop novel, biomimetic 3D NF scaffolds,
using our innovative technique of thermally induced nanofiber self-agglomeration (TISA). In Aim
2, we will develop the dual-release system of DFO and phenamil from a 3D NF scaffold to
modulate both angiogenesis and osteogenesis in aged cells in vitro. In Aim 3, we will investigate
the contribution of local and controlled release of DFO and phenamil from scaffolds for critical-
sized cranial bone defect repair in aged mice. The success of this project will establish a novel
strategy for challenged bone repair by improving endogenous tissue regeneration.
项目总结
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Hongli Sun其他文献
Hongli Sun的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Hongli Sun', 18)}}的其他基金
Rejuvenating aged bone regeneration by innovative nanomaterials-mediated drug delivery
通过创新纳米材料介导的药物输送使衰老的骨再生恢复活力
- 批准号:
10045736 - 财政年份:2020
- 资助金额:
$ 34.78万 - 项目类别:
Rejuvenating aged bone regeneration by innovative nanomaterials-mediated drug delivery
通过创新纳米材料介导的药物输送使衰老的骨再生恢复活力
- 批准号:
10194462 - 财政年份:2020
- 资助金额:
$ 34.78万 - 项目类别:
Rejuvenating aged bone regeneration by innovative nanomaterials-mediated drug delivery
通过创新纳米材料介导的药物输送使衰老的骨再生恢复活力
- 批准号:
10615065 - 财政年份:2020
- 资助金额:
$ 34.78万 - 项目类别:
Functionalized Nanofibrous Scaffold for Endogenous Bone Regeneration
用于内源性骨再生的功能化纳米纤维支架
- 批准号:
9770013 - 财政年份:2018
- 资助金额:
$ 34.78万 - 项目类别:
相似海外基金
Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
- 批准号:
MR/S03398X/2 - 财政年份:2024
- 资助金额:
$ 34.78万 - 项目类别:
Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
- 批准号:
EP/Y001486/1 - 财政年份:2024
- 资助金额:
$ 34.78万 - 项目类别:
Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
- 批准号:
2338423 - 财政年份:2024
- 资助金额:
$ 34.78万 - 项目类别:
Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
- 批准号:
MR/X03657X/1 - 财政年份:2024
- 资助金额:
$ 34.78万 - 项目类别:
Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
- 批准号:
2348066 - 财政年份:2024
- 资助金额:
$ 34.78万 - 项目类别:
Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
- 批准号:
AH/Z505481/1 - 财政年份:2024
- 资助金额:
$ 34.78万 - 项目类别:
Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 34.78万 - 项目类别:
EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
- 批准号:
2341402 - 财政年份:2024
- 资助金额:
$ 34.78万 - 项目类别:
Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 34.78万 - 项目类别:
EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
- 批准号:
AH/Z505341/1 - 财政年份:2024
- 资助金额:
$ 34.78万 - 项目类别:
Research Grant